AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsPricingSign inSign up free

PEMBROLIZUMAB

7 registrations across 7 African markets— 7 active

Markets with PEMBROLIZUMAB

🇨🇮Côte d'Ivoire
1 registration
1 active
🇬🇭Ghana
1 registration
1 active
🇰🇪Kenya
1 registration
1 active
🇷🇼Rwanda
1 registration
1 active
🇹🇿Tanzania
1 registration
1 active
🇿🇦South Africa
1 registration
1 active
🇿🇼Zimbabwe
1 registration
1 active

Recent registrations

Brand / ProductMarketHolderStatusExpires
KEYTRUDA
Concentrate for solution for infusion
🇷🇼RwandaBOEHRINGER INGELHEIM PHARMA GmbH & Co. KG.activeMay 2031
KEYTRUDA
SOLUTION; INFUSION
🇿🇼ZimbabweMSD (PTY) LTDactiveOct 2030
KEYTRUDA(100MG/4ML) CONCENTRATE FOR SOLUTION FOR INFUSION (PEMBROLIZUMAB 25MG/ML)🇬🇭Ghana—activeMay 2030
KEYTRUDA
Concentrate For Solution For Infusion
🇰🇪KenyaMSD (PTY) LTDactiveSept 2029
KEYTRUDA🇿🇦South AfricaMSD (Pty) LtdactiveJan 1900
Keytruda
Solution For Infussion
🇹🇿TanzaniaMSD (PTY) LTDactive—
KEYTRUDA 25 MG/ML SOLUTION À DILUER POUR PERFUSION IV, FLACON DE 4 ML.🇨🇮Côte d'IvoireMERCK SHARP & DOHME B.V.active—

PEMBROLIZUMAB in Africa — Regulatory Overview

PEMBROLIZUMAB is registered across 7 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Côte d'Ivoire, Ghana, Kenya, Rwanda and 3 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.